Print page

Development of highly active substances at Heraeus

Our wide range of services covers:
- Development of chemical and biotechnological processes
- Development of analytical methods
- Scale-up
- Internal Engineering Group supporting the development and production facilities
- Production of active substance batches for clinical studies under cGMP conditions
- Comprehensive regulatory support (RA Department)
- cGMP and DIN EN ISO 9001 conform quality management system backed by experience in Phase I-III and commercial products
Rubicine
As a partner for active agent development and synthesis on the basis of commissioned orders, Heraeus is characterised by a high reaction speed and great flexibility, combined with utmost reliability in terms of quality and on-time delivery.
Our customised services cover integrated project management and partnership project work ranging from all initial clinical active agent development activities right up to commercial production.

The know-how of our teams of highly qualified chemists, chemical engineers and bio-technologists form a sound basis for the efficient development of our pharmaceutical active agents.
To this must be added our development facilities adapted to specific product categories with which we are able to fulfil, in every respect, the specific requirements of our clients in all areas of process development work and the scale-up of highly active and/or cytotoxic active substances.